Published Date:2021-10-13
Original Link:https://www.onenessbio.com/en/news_detail63_1.htm
| No | 1 | Date of announcement | 2021/10/13 | Time of announcement | 17:22:30 |
|---|---|---|---|---|---|
| Subject | A Malaysian patent on the Anti-CεMx (FB825) antibody was granted. | ||||
| To which item it meets | paragraph 53 | Date of events | 2021/10/13 | ||
| Statement | |||||
|
1.Date of occurrence of the event:2021/10/13
2.Company name:ONENESS BIOTECH CO., LTD. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office 4.Reciprocal shareholding ratios:NA 5.Cause of occurrence:FB825,anti-CεmX antibody, has been granted an Malaysian patent titled ”ANTI-CεMX ANTIBODIES CAPABLE OF BNDING TO HUMAN MIGE ON B LYMPHOCYTES” under the patent number MY-183134-A. 6.Countermeasures:None 7.Any other matters that need to be specified:The assignee of the above-mentioned patent is Academia Sinica. Oneness Biotech owns the exclusive worldwide right of the patent for manufacture, use, and sale of the product. |
|||||